ETFs With Eli Lilly and Company (LLY) Exposure

The following ETFs maintain significant exposure to Eli Lilly and Company (LLY); each of the following funds counts LLY among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.

To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.

Ticker ETF ETFdb Category Expense Ratio Weighting
IHE iShares U.S. Pharmaceuticals ETF Health & Biotech Equities 0.48% 6.12%
PJP Dynamic Pharmaceuticals Health & Biotech Equities 0.60% 5.17%
PPH Market Vectors Pharmaceutical ETF Health & Biotech Equities 0.35% 4.52%
XPH SPDR S&P Pharmaceuticals ETF Health & Biotech Equities 0.35% 3.48%
FMK Mega Cap AlphaDEX Fund Large Cap Blend Equities 0.70% 3.08%
FDL Morningstar Dividend Leaders Index Fund Large Cap Value Equities 0.45% 2.74%
FXH Health Care AlphaDEX Health & Biotech Equities 0.70% 2.45%
SDOG Sector Dividend Dogs ETF Large Cap Value Equities 0.40% 2.33%
FTCS First Trust Capital Strength ETF Large Cap Value Equities 0.65% 2.11%
USMV MSCI USA Minimum Volatility ETF All Cap Equities 0.15% 1.50%
FTA Large Cap Value AlphaDEX Fund Large Cap Value Equities 0.70% 0.94%
FAB Multi Cap Value AlphaDEX Fund All Cap Equities 0.70% 0.47%

© 2014 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Enter a ticker symbol or keyword: